National and Kapodistrian University of Athens
Μελέτη των μορίων προσκόλλησης του ενδοθηλίου σε ασθενείς με αιμοσφαιρινοπάθειες
Abstract
dc:descriptionHemoglobinopathies are the most common single gene disorders worldwide, characterised by decreased (Thalassaemias) or abnormal (i.e. Sickle Cell Disease) globin chain synthesis. The role of endothelial activation in Sickle Cell Disease has been shown through many studies. However, there are only few in vitro studies concerning Thalassaemia. The purpose of this study was to determine the levels of certain endothelial activation markers which possibly interfere in the pathophysiology of Sickle Cell Disease and Thalassaemias. We included in our study 35 patients with Thalassaemia Intermedia (TI) and 28 patients with Sickle Cell Disease (SCD), selected from the Laboratory of Human Genetics of Athens University (Choremio Laboratory) and the First Department of Internal Medicine of the Medical School of Athens. 20 healthy individuals were included in the control group. Immuno-enzymatic assays, performed in the Biochemistry Laboratory of “Aghia Sophia” Children’s Hospital, were used to measure the serum levels of sICAM-1, sVCAM-1, thrombomoduline (sTM), P and E selectin, as well as the levels of two inflammation markers, CRP and serum amyloid (SAA). We used STATGRAFICS PLUS 5.1 for Windows (Graphic Software System) for the statistic analysis of our results. In the group of patients with SCD in steady state, the levels of endothelial activation markers were increased, confirming the activation and malfunction of the endothelium layer. Levels of CRP and SAA were also increased, reflecting the inflammation state of these patients. Treatment with hydroxyuria helped decrease the levels of sICAM, sVCAM και sΤΜ, but not significantly, whereas venesections did not result in any change. Furthermore, we did not observe any correlation of the levels of the above mentioned molecules with the degree of patients’ anemia. In the group of patients with TI, the levels of endothelial activation markers were increased, showing, as in the SCD group, endothelial activation. Levels of CRP and SAA were also increased, as a result of chronic inflammation of these patients. Treatment with hydroxyuria or splenectomy did not decrease the levels of the above mentioned molecules. Finally, as in the SCD group, we did not observe any correlation with the degree of patients’ anemia. As a conclusion, the results of this study confirm the role of endothelial activation in the pathophysiology of SCD and indicate that similar mechanisms, which have previously been described in patients with β-Thalassaemia Major, are implied in the pathogenesis of TI.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kanavaki, Ino
- Καναβάκη, Ινώ
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23186